Type 2 diabetes: A light-intensity walk after a meal would be beneficialStudy shows clinically significant reductions in postprandial glucose and insulin. How to better manage nocturnal blood glucose levels in type 1 diabetes patientsStudy points to benefits of algorithm-assisted insulin delivery to improve glucose management. Which treatment is most effective for diabetic peripheral neuropathy? Study examines the efficacy of three monotherapies and three combination therapies for diabetic peripheral neuropathy. New Canadian guideline for using GLP-1 agonists and SGLT2 inhibitors for cardiorenal risk reduction GLP-1 receptor agonists and SGLT2 inhibitors have proven cardiorenal benefits in patients with and without type 2 diabetes. Nitrosamine impurity found in diabetes drug FDA allows continued sale of drug, noting that risk outweighs patient benefit. Eating within a 10-hour window beneficial to type 2 diabetes Time-restricted eating contributes to better 24-hour glucose levels, study shows. Is type 2 diabetes becoming an obsolete diagnosis? Studies suggest T2D patients may benefit from a better subtyping of their diabetes—using 5 subtypes. Pharmacists can help to close the diabetes care gap When Rick Siemens from Lethbridge, graduated from the University of Alberta, he quickly realized that many of his patients with diabetes were struggling with their condition. Metformin improves symptoms in people with bipolar disorder: study Researchers from Dalhousie University find metformin may also heal blood-brain barrier dysfunction in patients with bipolar disorder. Off-the-shelf continuous glucose monitors may help diabetic-hemodialysis patients Study shows device can be reliable in this complex population. First Previous 11 12 13 14 15 Next Last
